Literature DB >> 15248823

Life events in the pathogenesis of hyperprolactinemia.

N Sonino1, C Navarrini, C Ruini, F Fallo, M Boscaro, G A Fava.   

Abstract

OBJECTIVE: Little is known about the relationship between recent life events and onset of hyperprolactinemia, despite the well-known effect of acute psychological stress on prolactin levels in healthy subjects. Recent life events in patients with hyperprolactinemia compared with healthy controls were investigated.
DESIGN: Case-control study.
METHODS: Fifty-two consecutive patients with hyperprolactinemia (45 females/7 males; mean age 34.9+/-10.1 years, range 18-60 years) and 52 healthy subjects matched for socio-demographic variables were studied. Nineteen patients (18 females/1 male) had no pituitary tumor and were diagnosed as suffering from idiopathic hyperprolactinemia. Patients with additional pathology or with high prolactin due to medications were excluded. All patients were interviewed by Paykel Interview for Recent Life Events while on remission after surgery or pharmacological treatment. The time period considered was the year preceding the first signs of hyperprolactinemia, and the year before interview for controls.
RESULTS: Patients with hyperprolactinemia reported significantly more life events than control subjects (P<0.001). The same significant difference compared with controls applied to patients with (n=16) and without (n=36) depression. All categories of events (except events that were likely to be under the subject's control) were significantly more frequent. There were no significant differences between patients with prolactinoma (n=33) and those with idiopathic hyperprolactinemia (n=19).
CONCLUSIONS: Within the complexity of phenomena implicated in the pathogenesis of hyperprolactinemia, our findings emphasize a potential role of emotional stress in either prolactin-secreting pituitary tumors or idiopathic hyperprolactinemia. Appraisal of life stress may have implications in clinical assessment (e.g. functional hyperprolactinemia) and decisions (e.g. termination of long-term pharmacological treatment).

Entities:  

Mesh:

Year:  2004        PMID: 15248823     DOI: 10.1530/eje.0.1510061

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

1.  The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy.

Authors:  Kristen D Kelley; Guerry Peavy; Steven Edland; Whitney Rogers; David E Riley; Yvette Bordelon; David Standaert; Stephen G Reich; Irene Litvan
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

2.  Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas.

Authors:  L G Sobrinho; J S Duarte; I Paiva; L Gomes; V Vicente; P Aguiar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 3.  Neuroimmunology of stress: skin takes center stage.

Authors:  Petra C Arck; Andrzej Slominski; Theoharis C Theoharides; Eva M J Peters; Ralf Paus
Journal:  J Invest Dermatol       Date:  2006-08       Impact factor: 8.551

Review 4.  Prolactin and human weight disturbances: A puzzling and neglected association.

Authors:  Luis G Sobrinho; Nelson D Horseman
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

5.  Reproductive Health Assessment of Female Elephants in North American Zoos and Association of Husbandry Practices with Reproductive Dysfunction in African Elephants (Loxodonta africana).

Authors:  Janine L Brown; Stephen Paris; Natalia A Prado-Oviedo; Cheryl L Meehan; Jennifer N Hogan; Kari A Morfeld; Kathy Carlstead
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

6.  Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.

Authors:  Rita Bettencourt-Silva; Joana Queirós; Josué Pereira; Davide Carvalho
Journal:  J Med Case Rep       Date:  2018-12-06

7.  Amenorrhea as a Side Effect of Low Dose Aripiprazole: An Adolescent Case.

Authors:  Ahmed Naguy
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-02-28       Impact factor: 2.582

8.  Body self-image disturbances in women with prolactinoma.

Authors:  Helen S Pereira; Erika C Naliato; Aline B Moraes; Monica R Gadelha; Leonardo Vieira Neto; Renan M Almeida; Antonio E Nardi; Alice H Violante
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

9.  Prolactin response to antipsychotics: An inpatient study.

Authors:  Liana Dehelean; Ana-Maria Romosan; Ion Papava; Cristina Ana Bredicean; Victor Dumitrascu; Sorin Ursoniu; Radu-Stefan Romosan
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

10.  Prolactin and aggression in women with fertility problems.

Authors:  J A Barry; E Moran; H S Parekh; T Morewood; M Thomas; P J Hardiman
Journal:  J Obstet Gynaecol       Date:  2014-10       Impact factor: 1.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.